Tubular protection with empagliflozin treatment in subjects with type 2 diabetes and cardiovascular disease: a sub-analysis of the EMPA-HEART CardioLink-6 trial E. Opingari,S. Verma, C. D. Mazer,K. A. Connelly,A. T. Yan,F. Zuo,T. Mason,B. Chowdhury,Y. Pan,A. Quan,H. Teoh,L. A. Leiter, B. Zinman,D. Z. I. Cherney,R. E. GilbertDIABETOLOGIA(2019)引用 1|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要